Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer

BJU International

Volumn 110, Issue 7, 2012, Pages 1062-1069

  Kim, Howard S ^a,b   Masko, Elizabeth M ^a   Poulton, Susan L ^a   Kennedy, Kelly M ^c   Pizzo, Salvatore V ^a   Dewhirst, Mark W ^a,c   Freedland, Stephen J ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE CANCER INSTITUTE   (United States)

Author keywords

carbohydrate; ketogenic; lactate; prostate cancer

Indexed keywords

ALPHA CYANO 4 HYDROXYCINNAMIC ACID; INSULIN; MONOCARBOXYLATE TRANSPORTER 1; CD31 ANTIGEN; COTRANSPORTER; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID DERIVATIVE; MONOCARBOXYLATE TRANSPORT PROTEIN 1; MONOCARBOXYLATE TRANSPORTER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOXIC CELL; INSULIN BLOOD LEVEL; KETOGENIC DIET; LIPID DIET; LOW CARBOHYDRATE DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DIET; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; TUMOR NECROSIS; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CELL PROLIFERATION; DISEASE MODEL; DRUG ANTAGONISM; METABOLISM; NECROSIS; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE; XENOGRAFT;

ANIMALS; ANTIGENS, CD31; BODY WEIGHT; CELL PROLIFERATION; DIET, CARBOHYDRATE-RESTRICTED; DISEASE MODELS, ANIMAL; ENERGY INTAKE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KETOGENIC DIET; LACTATES; MALE; MICE; MICE, NUDE; MONOCARBOXYLIC ACID TRANSPORTERS; NECROSIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; SYMPORTERS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84871706742     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.10971.x     Document Type: Article

References (19)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
2. Freedland SJ, Mavropoulos J, Wang A, et al,. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 2008; 68: 11-9
3. Tymchuk CN, Barnard RJ, Ngo TH, Aronson WJ,. Role of testosterone, estradiol, and insulin in diet- and exercise-induced reductions in serum-stimulated prostate cancer cell growth in vitro. Nutr Cancer 2002; 42: 112-6
4. Roddam AW, Allen NE, Appleby P, et al,. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008; 149: 461-71, W83-8
5. Schroeder T, Yuan H, Viglianti BL, et al,. Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res 2005; 65: 5163-71
6. Sonveaux P, Vegran F, Schroeder T, et al,. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-42
7. Moeller BJ, Dreher MR, Rabbani ZN, et al,. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 2005; 8: 99-110
8. Movsas B, Chapman JD, Horwitz EM, et al,. Hypoxic regions exist in human prostate carcinoma. Urology 1999; 53: 11-8
9. Helmlinger G, Yuan F, Dellian M, Jain RK,. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3: 177-82
10. Ebert BL, Firth JD, Ratcliffe PJ,. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 1995; 270: 29083-9
11. Thomas R, Kim MH,. HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells. Prostate 2008; 68: 1405-15
12. Thomas JA 2nd, Antonelli JA, Lloyd JC, et al,. Effect of intermittent fasting on prostate cancer tumor growth in a mouse model. Prostate Cancer Prostatic Dis 2010; 13: 350-5
13. Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F, Baltazar F,. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol 2010; 2010: 427694
14. Pinheiro C, Albergaria A, Paredes J, et al,. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 2010; 56: 860-7
15. Hao J, Chen H, Madigan MC, et al,. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Br J Cancer 2010; 103: 1008-18
16. Mavropoulos JC, Isaacs WB, Pizzo SV, Freedland SJ,. Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? Urology 2006; 68: 15-8
17. Halestrap AP,. The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem J 1975; 148: 85-96
18. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK,. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 1999; 91: 512-23
19. Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, Verma A,. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 2005; 280: 41928-39